Traduction de «487 » (Français → Néerlandais) :

RINGS 2/3 RING W 7-HOLE M-TAB INNER DIAMETER 105MM 71070132X 615,75 FULL RING W 7-HOLE M-TAB INNER DIAMETER 71070112X 482,31 105MM FULL RING W 7-HOLE M-TAB INNER DIAMETER 71070117X 482,31 230MM FOOT RING 155MM LONG 71070144 482,31 FOOT RING 180MM LONG 71070145 482,31 FOOT RING 155MM SHORT 71070154 482,31 FOOT RING 180MM SHORT 71070155 482,31 U-PLATE 80MM 71071301 482,31 U-PLATE 105MM 71071302 482,31 U-PLATE 130MM 71071303 487,60 U-PLATE 155MM 71071304 487,60 U-PLATE 180MM 71071305 487,60
FULL RING W 7-HOLE M-TAB INNER DIAMETER 71070112X 482,31 105MM FULL RING W 7-HOLE M-TAB INNER DIAMETER 71070117X 482,31 230MM FOOT RING 155MM LONG 71070144 482,31 FOOT RING 180MM LONG 71070145 482,31 FOOT RING 155MM SHORT 71070154 482,31 FOOT RING 180MM SHORT 71070155 482,31 U-PLATE 80MM 71071301 482,31 U-PLATE 105MM 71071302 482,31 U-PLATE 130MM 71071303 487,60 U-PLATE 155MM 71071304 487,60 U-PLATE 180MM 71071305 487,60

C10AA INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 372.658.546 C10AB FIBRATES 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 C10AC + C10AD + C10AX AUTRES HYPOLIPIDEMIANTS 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 Total 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561 399.962.995
C10AA HMG-CoA REDUCTASE - REMMERS (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 372.658.546 C10AB FIBRATEN 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 C10AC + C10AD + C10AX ANDERE HYPOLIPEMIERENDE MIDDELEN 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 Totaal 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561 399.962.995

C10AA INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 372.658.546 464.861.301 C10AB FIBRATES 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 33.123.513 C10AC + C10AD + C10AX AUTRES HYPOLIPIDEMIANTS 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 5.610.959 Total 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561 399.962.995 503.595.772
C10AA HMG-CoA REDUCTASE - REMMERS (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 372.658.546 464.861.301 C10AB FIBRATEN 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 33.123.513 C10AC + C10AD + C10AX ANDERE HYPOLIPEMIERENDE MIDDELEN 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 5.610.959 Totaal 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561 399.962.995 503.595.772

C10AA INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES) 95.692.129 140.940.122 167.718.993 191.686.825 228.282.777 312.348.909 372.658.789 411.279.082 457.722.112 C10AB FIBRATES 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 29.742.901 30.183.448 C10AC + C10AD + C10AX AUTRES HYPOLIPIDEMIANTS 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 4.640.263 6.334.594 Total 156.582.515 197.201.188 222.822.606 255.487.049 290.797.754 353.219.648 399.963.238 445.662.246 494.240.155
C10AA HMG-CoA REDUCTASE - REMMERS (STATINES) 95.692.129 140.940.122 167.718.993 191.686.825 228.282.777 312.348.909 372.658.789 411.279.082 457.722.112 C10AB FIBRATEN 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 24.223.503 29.742.901 30.183.448 C10AC + C10AD + C10AX ANDERE HYPOLIPEMIERENDE MIDDELEN 452.967 398.015 365.126 351.024 344.699 824.519 3.080.946 4.640.263 6.334.594 Totaal 156.582.515 197.201.188 222.822.606 255.487.049 290.797.754 353.219.648 399.963.238 445.662.246 494.240.155

C10AA INHIBITEURS DE LA HMG-CoA REDUCTASE (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 C10AB FIBRATES 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 C10AC + C10AD + C10AX AUTRES HYPOLIPIDEMIANTS 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 Total 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561
C10AA HMG-CoA REDUCTASE - REMMERS (STATINES) 29.943.315 51.414.603 95.692.129 140.940.122 167.718.993 191.686.825 228.282.770 312.348.823 C10AB FIBRATEN 66.106.101 66.301.254 60.437.420 55.863.051 54.738.487 63.449.200 62.170.278 40.046.220 C10AC + C10AD + C10AX ANDERE HYPOLIPEMIERENDE MIDDELEN 760.428 604.443 452.967 398.015 365.126 351.024 344.699 824.519 Totaal 96.809.844 118.320.300 156.582.515 197.201.188 222.822.606 255.487.049 290.797.747 353.219.561

Etat-produits TVA + accises tabac 2310 518 0 0 0 2310 518 Financement alternatif - Loi Hôpitaux 1 487 241 - - - 1 487 241 Financement alternatif - Divers 823 277 - - - 823 277
Opbrengst BTW - Tabaksaccijnzen 2310 518 0 0 0 2310 518 Alt. Financiering - Wet ziekenhuizen 1 487 241 - - - 1 487 241 Alt. Financiering - Diversen 823 277 - - - 823 277

100 à 199 N 487 0 487 202 103 70 29 297 5 180 36 76 986 travailleurs % 56,2% 56,2% 51,9% 55,4% 57,9% 35,4% 49,2% 62,5% 53,3% 51,4% 40,4% 53,0%
100 tot 199 N 487 0 487 202 103 70 29 297 5 180 36 76 986 werknemers % 56,2% 56,2% 51,9% 55,4% 57,9% 35,4% 49,2% 62,5% 53,3% 51,4% 40,4% 53,0%

SPF Santé publique 1487 241 0 0 0 1487 241 Hôpitaux (22,77% prix de journée, MSP, 1 487 241 - - - 1 487 241 habitations protégées, détenus, autres institutions & internés)
FOD Volksgezondheid 1487 241 0 0 0 1487 241 Ziekenhuizen (22,77% ligdag), PVT, beschut 1 487 241 - - - 1 487 241 wonen,gevangenen, andere instell.& geïnterneerden

Opinion on the scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies (format PDF - 22 pages - 487 KB).
Opinion on the scientific aspects of the existing and proposed definitions relating to products of nanoscience and nanotechnologies (PDF, 22 p., 487 KB).

Un guide pour l'employeur et les partenaires sociaux 1.056 Lage rugpijn op het werk 316 DANS LES METIERS (A5) Prévention du mal de dos chez le coffreur 700 Preventie van rugpijn bij bekisters 88 Prévention du mal de dos chez le couvreur 343 Preventie van rugpijn bij dakdekkers 0 Prévention du mal de dos chez le ferrailleur 625 Preventie van rugpijn bij betonvlechters 788 Prévention du mal de dos chez le grutier 440 Preventie van rugpijn bij kraanbestuurders 487 Prévention du mal de dos chez le monteur 729
Un guide pour l'employeur et les partenaires sociaux 1.056 Lage rugpijn op het werk 316 BIJ BEROEPEN (A5) Prévention du mal de dos chez le coffreur 700 Preventie van rugpijn bij bekisters 88 Prévention du mal de dos chez le couvreur 343 Preventie van rugpijn bij dakdekkers 0 Prévention du mal de dos chez le ferrailleur 625 Preventie van rugpijn bij betonvlechters 788 Prévention du mal de dos chez le grutier 440 Preventie van rugpijn bij kraanbestuurders 487 Prévention du mal de dos chez le monteur 729 Preventie van rugpijn bij monteurs 748 Prévention du mal de dos chez le terrassier 236 Preventie van rugpijn bij grondwerkers 910 TMS personnel de l'aide à domicile 3.322 MSA personeel uit de sector van de thuishulp 1.650